BRST5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 368: Line 368:
|COMPLETE
|COMPLETE
|
|
|Hui Chen / Katherine Geiersbach
|Katherine Geiersbach
|12/6/2023
|1/8/2025
|2021 template added
|2024 template added
|-
|-
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen / Morteza Seifi
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen / Morteza Seifi
|10/12/2022
|10/12/2022
|11/11/2023
|11/11/2023
|COMPLETE
|PENDING
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|
|
|2021 template added
|2024 template added
|-
|-
|Mucoepidermoid carcinoma||Disease||
|Mucoepidermoid carcinoma||Disease||
Line 405: Line 405:
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|
|1/8/2025
|2021 template added
|2024 template added
|-
|-
|Neuroendocrine tumour||Disease||
|Neuroendocrine tumour||Disease||
Line 468: Line 468:
|-
|-
|[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
|[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
|8/11/2023
|
|11/11/2023
|
|PENDING
|PENDING
|
|
|
|
|
|
|2021 template added
|2024 template added
|-
|-
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
Line 483: Line 483:
|
|
|
|
|2021 template added
|2024 template added
|-
|-
|
|
Line 644: Line 644:
|Katherine Geiersbach
|Katherine Geiersbach
|12/27/2024
|12/27/2024
|2024 template  
|2024 template
|-
|-
|Schwannoma||Disease||
|Schwannoma||Disease||